NUBURU, Inc. (NYSE American: BURU) announced the closing of its previously disclosed $12 million public offering and expects trading on the NYSE American to resume on March 2, 2026, following a 1-for-4.99 reverse stock split. The reverse split is intended to bring the company's share price above the exchange's minimum bid price requirement, after trading was halted on February 13, 2026, when the stock fell below $0.10. Management cautioned that if the price again drops below that threshold after trading resumes, the shares could be halted and potentially delisted.
The offering included 58,379,137 shares of common stock, 50,711,772 pre-funded warrants, and common warrants exercisable for up to 163,636,364 shares. Joseph Gunnar & Co. LLC served as the exclusive placement agent. The proceeds are expected to support NUBURU's strategic transformation from a laser-technology company into a dual-use Defense & Security platform provider. According to the press release, the company is focusing on proprietary directed-energy technologies, non-kinetic defense capabilities, mission-critical software, and targeted industrial partnerships and acquisitions to address high-value defense, security, and operational-resilience markets.
Founded in 2015, NUBURU is now executing this transformation to capitalize on growing demand for advanced defense solutions. The company's ability to resume trading and maintain compliance will be closely watched by investors, as the reverse stock split and offering provide a capital infusion but also highlight the volatility and risks associated with penny stocks. The full details of the offering are available at https://ibn.fm/WBfNf. For more information about NUBURU, visit www.nuburu.net.
This announcement is significant as it underscores NUBURU's efforts to stabilize its financial position and pivot toward defense and security markets, which may offer higher growth potential. However, the risk of future non-compliance remains, and investors should monitor the stock's performance after trading resumes. The offering's structure, including a large number of warrants, could lead to dilution if exercised. The company's ability to execute its strategic plan will be critical to its long-term viability.
